RegCell

🗓 Founded 2016👥 13 employees💰 Last funded 2026
Biotechnology Research
LinkedIn
Based on the discovery by our Founder, Professor Shimon Sakaguchi, we are developing stable, functional-induced Tregs that are antigen-specific (S/F-iTregs). Our S/F-iTregs address the limitations of earlier attempts to create therapeutic Tregs and competitive advantages over CAR-Treg approaches.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in RegCell?
RegCell has 1 investors on record on gritt.io and 1 late-stage investors.
When did RegCell last raise funding?
The most recent investment in RegCell recorded on gritt.io was in 2026.
When was RegCell founded?
RegCell was founded in 2016.
What industry is RegCell in?
RegCell operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.